Many of the treatments and services that cancer patients avail of are not solely provided for cancer patients. It is therefore difficult to define the total cost of provision of cancer treatments in the public system, as it is spread across the entire acute hospitals funding allocation. While it does not comprise the total annual cost to the State of delivering cancer treatment in the public system, the funding allocation for the HSE's National Cancer Control Programme (NCCP) is used for cancer-specific programmes and the continued implementation of the National Cancer Strategy 2017-2026.
The funding allocation for the NCCP from 2018-2021 is as follows:
Organization
|
2018 €m
|
2019 €m
|
2020 €m
|
2021 €m
|
National Cancer Control Programme
|
85.8
|
94.2
|
98.1
|
130.2
|